Kvgab-NT Tablet is a combination medication containing Pregabalin 75 mg and Nortriptyline 10 mg, indicated primarily for the management of neuropathic pain and certain types of chronic pain disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its effect by modulating calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances pain relief through its inhibition of norepinephrine and serotonin reuptake, contributing to its analgesic and mood-stabilizing properties. The combination of these agents provides a synergistic effect, improving efficacy in patients who may not respond adequately to monotherapy. Kvgab-NT is typically prescribed for conditions such as diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and other neuropathic pain syndromes. Dosage should be individualized based on patient response and tolerability, with careful consideration of potential side effects including dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac disorders, glaucoma, or those taking other central nervous system depressants. Regular monitoring and adherence to prescribed regimens are essential to optimize therapeutic outcomes and minimize adverse effects.